Bioanalytical Testing Services Market Research Report by Type, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Bioanalytical Testing Services Market size was estimated at USD 3,619.00 million in 2021 and expected to reach USD 3,957.38 million in 2022, and is projected to grow at a CAGR 9.52% to reach USD 6,247.65 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Bioanalytical Testing Services to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Biomarker Testing, Cell-Based Assays, Method Development Optimization & Validation, Pharmacokinetic Testing, Serology, Immunogenicity, & Neutralizing Antibodies, and Virology Testing. The Cell-Based Assays is further studied across Bacterial Cell-Based Assays and Viral Cell-Based Assays. The Virology Testing is further studied across In Vitro Virology Testing, In Vivo Virology Testing, and Species-Specific Viral PCR Assays.

Based on Application, the market was studied across Cardiology, Gastroenterology, Infectious Diseases, Neurology, and Oncology.

Based on End User, the market was studied across Contract Development & Manufacturing Organizations, Contract Research Organizations, and Pharmaceutical & Biopharmaceutical Companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Bioanalytical Testing Services market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bioanalytical Testing Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bioanalytical Testing Services Market, including Almac Group, Altasciences Company, Inc., BioAgilytix Labs, LLC, Celerion, Charles River Laboratories International, Inc., Eurofins Scientific, Frontage Laboratories, Inc., Icon PLC, Intertek Group plc, IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, LGC Group, Lotus Labs Pvt. Ltd., Medpace Holdings, Inc., Parexel International Corporation, Pharmaceutical Research Associates Inc., PPD Inc., SGS SA, Syneos Health, LLC, and WuXi AppTec Co., Ltd.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Bioanalytical Testing Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bioanalytical Testing Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bioanalytical Testing Services Market?
4. What is the competitive strategic window for opportunities in the Global Bioanalytical Testing Services Market?
5. What are the technology trends and regulatory frameworks in the Global Bioanalytical Testing Services Market?
6. What is the market share of the leading vendors in the Global Bioanalytical Testing Services Market?
7. What modes and strategic moves are considered suitable for entering the Global Bioanalytical Testing Services Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising focus on the analytical testing of biologics and biosimilars
5.1.1.2. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
5.1.1.3. Rising adoption of the quality by design approach
5.1.2. Restraints
5.1.2.1. Pricing pressure and dearth of skilled professionals faced by major players
5.1.3. Opportunities
5.1.3.1. Rising demand for specialized bioanalytical testing services in developing economies
5.1.3.2. Increasing economic efficiency offered for outsourcing rather than conducting an in-house study
5.1.3.3. Emergence of technological advancements and approvals of clinical trials in the bioanalytical testing services
5.1.4. Challenges
5.1.4.1. Concerns regarding innovative formulations demanding a unique bioanalytical testing approach
5.2. Cumulative Impact of COVID-19

6. Bioanalytical Testing Services Market, by Type
6.1. Introduction
6.2. Biomarker Testing
6.3. Cell-Based Assays
6.4.1. Bacterial Cell-Based Assays
6.4.2. Viral Cell-Based Assays
6.4. Method Development Optimization & Validation
6.5. Pharmacokinetic Testing
6.6. Serology, Immunogenicity, & Neutralizing Antibodies
6.7. Virology Testing
6.8.1. In Vitro Virology Testing
6.8.2. In Vivo Virology Testing
6.8.3. Species-Specific Viral PCR Assays

7. Bioanalytical Testing Services Market, by Application
7.1. Introduction
7.2. Cardiology
7.3. Gastroenterology
7.4. Infectious Diseases
7.5. Neurology
7.6. Oncology

8. Bioanalytical Testing Services Market, by End User
8.1. Introduction
8.2. Contract Development & Manufacturing Organizations
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biopharmaceutical Companies

9. Americas Bioanalytical Testing Services Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bioanalytical Testing Services Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Bioanalytical Testing Services Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Almac Group
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Altasciences Company, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. BioAgilytix Labs, LLC
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Celerion
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Charles River Laboratories International, Inc.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Eurofins Scientific
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Frontage Laboratories, Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Icon PLC
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Intertek Group plc
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. IQVIA Holdings, Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Laboratory Corporation of America Holdings
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. LGC Group
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Lotus Labs Pvt. Ltd.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Medpace Holdings, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Parexel International Corporation
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Pharmaceutical Research Associates Inc.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. PPD Inc.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. SGS SA
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Syneos Health, LLC
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. WuXi AppTec Co., Ltd
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing